FDA-cleared profile

BriefCase

Aidoc Medical, Ltd. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel occlusion, cervical-spine fracture-related findings, and pulmonary embolism-related findings for trained professional review.

Clinical role
Case-level triage, notification, and worklist prioritization for supported CT studies.
Images and patients
CT/CTA · Adult head, brain, cervical spine, pulmonary arteries, and thorax
Key limitation
Keep in mind: BriefCase is a triage and notification aid, not a standalone diagnosis or rule-out system. Professionals must review the complete source study and follow standard of care; exact indication, acquisition, and single-energy CTPA limits apply.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel occlusion, cervical-spine fracture-related findings, and pulmonary embolism-related findings for trained professional review.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Adult head, brain, cervical spine, pulmonary arteries, and thorax Input: Supported DICOM CT and CTA examinations received through the hospital imaging network.
  • Who uses it?Intended users: Appropriately trained medical specialists in hospital networks.
  • What does the software produce?Output: Case-level notifications, worklist priority, and compressed previews or findings for professional review; original images are not replaced.
  • What is its most important limitation?Key limitation: BriefCase is a triage and notification aid, not a standalone diagnosis or rule-out system. Professionals must review the complete source study and follow standard of care; exact indication, acquisition, and single-energy CTPA limits apply.

Clinical takeaway. Clinical role: BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel occlusion, cervical-spine fracture-related findings, and pulmonary embolism-related findings for trained professional review.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports that performance data was not needed to support this modification to BriefCase, which broadens the intended use population from radiologists to appropriately trained medical specialists; each 510(k) summary in the document refers to the earlier BriefCase 510(k) summary for the data used to support initial clearance. Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel occlusion, cervical-spine fracture-related findings, and pulmonary embolism-related findings for trained professional review.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Case-level triage, notification, and worklist prioritization for supported CT studies.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Supported DICOM CT and CTA examinations received through the hospital imaging network.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Case-level notifications, worklist priority, and compressed previews or findings for professional review; original images are not replaced.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Hospital radiology and acute-care triage workflows.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Appropriately trained medical specialists in hospital networks.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
BriefCase is a triage and notification aid, not a standalone diagnosis or rule-out system. Professionals must review the complete source study and follow standard of care; exact indication, acquisition, and single-energy CTPA limits apply.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
The exact FDA document reports that performance data was not needed to support this modification to BriefCase, which broadens the intended use population from radiologists to appropriately trained medical specialists; each 510(k) summary in the document refers to the earlier BriefCase 510(k) summary for the data used to support initial clearance. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Performance data was not needed to support this modification to BriefCase. The 510(k) Summary for K190896 describes the data that was used to support initial clearance of BriefCase." … "The only difference is that the subject device has a broadened intended use population of appropriately trained medical specialists, whereas the predicate device is indicated for use by radiologists.". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports that performance data was not needed to support this modification to BriefCase, which broadens the intended use population from radiologists to appropriately trained medical specialists; each 510(k) summary in the document refers to the earlier BriefCase 510(k) summary for the data used to support initial clearance. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Performance data was not needed to support this modification to BriefCase. The 510(k) Summary for K190896 describes the data that was used to support initial clearance of BriefCase." … "The only difference is that the subject device has a broadened intended use population of appropriately trained medical specialists, whereas the predicate device is indicated for use by radiologists.". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
91.7% (95% CI: 82.7%, 96.9%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
88.6% (95% CI: 81.2%, 93.8%)
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K203508 FDA evidence package for BriefCase

  • DesignFDA 510(k) decision evidence and product verification for the exact submission.
  • PopulationAdult head, brain, cervical spine, pulmonary arteries, and thorax
  • Scopeexact submission
  • Tested versionBriefCase
  • IndependenceSponsor or vendor study

K203508

FDA-submitted evidence for the exact decision; it is not independent clinical validation and does not establish local production qualification.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
No record matched K203508 by exact native submission identifier in the 2026-09-02 openFDA snapshot; this does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

No product-specific code

No exact-product reimbursement determination identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This public-policy review is not a coverage determination. Verify payer, site-of-service, coding, and local value assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Supported DICOM CT and CTA examinations received through the hospital imaging network.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K203508: BriefCase

  2. Routing

    Source context, not route validation: The FDA package describes an Aidoc Health Solutions platform, Aidoc Cloud Server, and desktop Worklist receiving, filtering, de-identifying, and returning DICOM-based notifications in a hospital network.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) decision material K203508: BriefCase

  3. AI processing

    Source context, not route validation: The FDA package describes an Aidoc Cloud Server plus desktop Worklist and hospital-network workflow; current hosting responsibility, security, availability, and site configuration remain unknown.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 · FDA 510(k) decision material K203508: BriefCase

  4. Returned objects

    Source context, not route validation: Case-level notifications, worklist priority, and compressed previews or findings for professional review; original images are not replaced.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K203508: BriefCase

  5. Viewer/worklist/report

    Unresolved route: Case-level notifications, worklist priority, and compressed previews or findings for professional review; original images are not replaced.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K203508: BriefCase

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA package describes an Aidoc Cloud Server plus desktop Worklist and hospital-network workflow; current hosting responsibility, security, availability, and site configuration remain unknown.
  • Exact FDA submission
  • Checked 2026-09-04
Integration
The FDA package describes an Aidoc Health Solutions platform, Aidoc Cloud Server, and desktop Worklist receiving, filtering, de-identifying, and returning DICOM-based notifications in a hospital network.
  • Exact FDA submission
  • Checked 2026-09-04
Security
Aidoc's current public Security & Privacy page says its security work is led by a CISO and security team, that it has adopted the NIST Cybersecurity Framework, and that its platform runs on AWS and Azure using EDR, encryption, SIEM and CSPM tooling. The page's list of standards and certifications did not load as readable text, so no certification is stated here.
  • Vendor-wide
  • Checked 2026-10-25

Vendor-wide marketing statement, not an independent attestation. It does not establish certificate scope or expiry, the controls of this exact release, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.

Training
Use by appropriately trained medical specialists in hospital networks. Follow the exact labeling, local training, supervision, and escalation requirements.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor labeled population, acquisition quality, exclusions, reviewer overrides, failures, and downstream workflow effects for K203508.
  • Exact FDA submission
  • Checked 2026-09-04

Release and scope verification

Map installed build, options, population, anatomy, inputs, outputs, and enabled functions to K203508.

exact submission · checked 2026-09-04

Deployment boundary

The FDA package describes an Aidoc Cloud Server plus desktop Worklist and hospital-network workflow; current hosting responsibility, security, availability, and site configuration remain unknown.

exact submission · checked 2026-09-04

Interoperability acceptance

The FDA package describes an Aidoc Health Solutions platform, Aidoc Cloud Server, and desktop Worklist receiving, filtering, de-identifying, and returning DICOM-based notifications in a hospital network.

exact submission · checked 2026-09-04

Clinical acceptance

Test labeled population, acquisition quality, exclusions, failed inputs, reviewer overrides, and downstream effects for K203508.

exact submission · checked 2026-09-04

Economic evaluation

Exact-product price, implementation cost, reimbursement, and total-cost evidence remain to be obtained; do not infer them from FDA clearance.

product family · checked 2026-09-04

Lifecycle monitoring

Monitor labeling, software version, complaints, recalls, failed inputs, overrides, and postmarket signals against the exact submission and installed configuration.

exact submission · checked 2026-09-04
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K203508
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Adult head, brain, cervical spine, pulmonary arteries, and thorax
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2020-12-29
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
12Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads

No evidence was promoted. PMID 41444826 names Aidoc Medical Briefcase ICH Triage but omits the tested software version and K203508; all remaining records are unrelated briefcase alias matches or unrelated trials. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price or commercial contract for the exact submission and version was identified.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No exact-product payer coverage or reimbursement determination was identified in reviewed public material.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

8 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K203508: BriefCase

    U.S. Food and Drug Administration - Published 2020-12-29 - Accessed 2026-09-04

    Scope: identity, submission_linkage, modality, anatomy, clinical_use, intended_users, care_setting, workflow_role, input, output, limitations, evidence

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BriefCase-C-Spine Fracture Triage model card (K203508)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

    Scope: intendedUsers, output, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  7. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  8. Aidoc Security & Privacy

    Aidoc Medical - Accessed 2026-10-25

    Scope: security

Research history

  1. K203508 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K200921

qER

Qure.ai Technologies

qER is a radiological computer aided triage and notification software indicated for use in the analysis of non-contrast head CT images. The device is intended to assist hospital networks and trained medical specialists in workflow triage by flagging the following suspected positive findings of pathologies in head CT images: intracranial hemorrhage, mass effect, midline shift and cranial fracture. qER uses an artificial intelligence algorithm to analyze images on a Stand-Alone Performance cloud-based application in parallel to the ongoing standard of care image interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-06-17
FDA-cleared K190072

BriefCase

Aidoc Medical, Ltd.

Authorized purpose: BriefCase is a radiological computer aided triage and notification software indicated for use in the analysis of non-enhanced CT and CTPA images. The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communication of suspected positive findings of Intracranial Hemorrhage and Pulmonary Embolism pathologies. For the PE pathology, the software is only intended to be used on single-energy exams.

Modality
CT/CTA
Anatomy
Brain; Chest/Lung
Decision
2019-04-15
FDA-cleared K252421

JLK-NCCT

JLK, Inc.

Authorized purpose: Notification-only triage of adult non-contrast head CT for suspected intracranial hemorrhage and large-vessel occlusion, with parallel communication to trained clinicians during standard care.

Modality
CT/CTA
Anatomy
Brain and intracranial vessels: intracranial hemorrhage and LVO involving ICA, MCA-M1, and MCA-M2
Decision
2026-03-24
FDA-cleared K253578

BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device

Aidoc Medical, Ltd.

Authorized purpose: BriefCase-Triage CARE Multi-Triage CT analyzes contrast and non-contrast chest, abdomen, or chest/abdomen CT in adults or transitional adolescents aged 18 and older to flag suspected pneumothorax, pericardial effusion, large aortic aneurysm, or shoulder fracture/dislocation for hospital-network workflow triage; notifications and previews are for prioritization, not diagnosis.

Modality
CT/CTA
Anatomy
Chest and abdomen; pneumothorax, pericardial effusion, large aortic aneurysm, and shoulder fracture/dislocation
Decision
2026-02-26

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history